ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Summary

ARS Pharmaceuticals (Nasdaq: SPRY) will participate in the Piper Sandler 37th Annual Healthcare Conference in New York, December 2-4, 2025.

Company executives Richard Lowenthal, Co-Founder, President and CEO, and Eric Karas, Chief Commercial Officer, will take part in a fireside chat on Wednesday, December 3 at 2:30 pm ET with Piper Sandler analyst David Amsellem. Management will hold one-on-one investor meetings. A live webcast of the fireside chat will be available on the company website and a replay will be archived for 90 days.

News Market Reaction – SPRY

+3.13%

1 alert

+3.13% Session close to close

$917.32M Market Cap

4.91K Volume

In the Nov 26 session, SPRY gained 3.13%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights ARS Pharmaceuticals’ participation in the Piper Sandler 37th Annual Hea...

Analysis

This announcement highlights ARS Pharmaceuticals’ participation in the Piper Sandler 37th Annual Healthcare Conference, including a December 3 fireside chat at 2:30 pm ET and one-on-one investor meetings. It reinforces ongoing investor-relations efforts following recent commercial and financial updates. The archived webcast, available for 90 days, offers additional access for stakeholders tracking neffy®’s rollout and corporate strategy. Investors may watch for subsequent earnings reports, new clinical data, and regulatory developments to refine their view of the story.

Key Figures

Conference edition: 37th Annual Conference dates: December 2–4, 2025 Fireside chat time: 2:30 pm ET +1 more

4 metrics

Conference edition 37th Annual Piper Sandler Healthcare Conference

Conference dates December 2–4, 2025 Piper Sandler Healthcare Conference schedule

Fireside chat time 2:30 pm ET December 3 investor fireside chat

Webcast replay period 90 days Archived replay of Piper Sandler fireside chat

Historical Context

5 past events · Latest: Nov 26 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Nov 26	Conference participation	Neutral	+3.1%	Announcement of Piper Sandler healthcare conference fireside chat and investor meetings.
Nov 10	Earnings results	Neutral	+0.3%	Q3 2025 financials and neffy commercial progress with higher revenue and losses.
Nov 04	Access program launch	Positive	+1.0%	Launch of Get neffy on Us program to expand access to neffy.
Nov 03	Scientific meeting data	Positive	-3.8%	Real-world neffy data presentations at ACAAI annual scientific meeting.
Nov 03	Earnings call notice	Neutral	-3.8%	Scheduling of Q3 2025 conference call and webcast for investors.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news usually produced modest price moves largely aligned with the news tone, with one negative divergence on a scientific conference update.

Recent Company History

Over the last month, ARS Pharmaceuticals has reported Q3 2025 financial results, launched the Get neffy on Us access program, and highlighted multiple neffy® data presentations at the ACAAI meeting. These updates, along with earnings-related webcasts and today’s Piper Sandler conference participation, show an active commercial and investor-relations push around neffy. Price reactions have mostly been modest and directionally consistent with generally constructive news flow, except for a negative reaction to scientific meeting disclosures.

Key Terms

anaphylaxis, webcast

2 terms

anaphylaxis medical

"protect themselves from allergic reactions that could lead to anaphylaxis"

Anaphylaxis is a sudden, severe allergic reaction in which the body's defense system overreacts to a trigger (like a drug, food, or insect sting), causing widespread symptoms such as difficulty breathing, low blood pressure, and shock; it can be life‑threatening without prompt treatment. Investors care because anaphylaxis risks can affect a drug or product's safety profile, regulatory approval, liability exposure and market acceptance—similar to a sprinkler system going off and damaging the whole house rather than just one room.

webcast technical

"A live webcast of the fireside chat will be available here"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced its participation at the Piper Sandler 37^th Annual Healthcare Conference, December 2-4, 2025, in New York.

Richard Lowenthal, Co-Founder, President and CEO and Eric Karas, Chief Commercial Officer will participate in a fireside chat on Wednesday, December 3 at 2:30 pm ET with Piper Sandler analyst David Amsellem. Company management will also participate in one-on-one meetings with investors.

A live webcast of the fireside chat will be available here, and in the Investors & Media section of the Company’s website. A replay of the webcast will be archived on the Company’s website for 90 days.

About ARS Pharmaceuticals, Inc.
ARS Pharma is a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions that could lead to anaphylaxis. The Company is commercializing neffy® (trade name EURneffy® in the EU), an epinephrine nasal spray indicated in the U.S. for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult patients and pediatric patients 4 years of age and older who weigh 33 lbs. or greater, and in the EU for emergency treatment of allergic reactions (anaphylaxis) due to insect stings or bites, foods, medicinal products, and other allergens as well as idiopathic or exercise induced anaphylaxis in adults and children who weigh 30 kg or greater. For more information, visit www.ars-pharma.com.

Investor Contact:
Justin Chakma, ARS Pharma
justinc@ars-pharma.com

Media Contact:
Christy Curran, Sam Brown Inc.
christycurran@sambrown.com
615.414.8668

FAQ

When will ARS Pharmaceuticals (SPRY) present at the Piper Sandler 37th Annual Healthcare Conference?

ARS will participate December 2-4, 2025, with a fireside chat on December 3, 2025 at 2:30 pm ET.

Who from ARS Pharmaceuticals (SPRY) will speak at the Piper Sandler conference?

Richard Lowenthal, Co-Founder, President and CEO, and Eric Karas, Chief Commercial Officer.

How can investors watch ARS Pharmaceuticals' (SPRY) fireside chat on December 3, 2025?

A live webcast will be available on the company's Investors & Media website, with a replay archived for 90 days.

Will ARS Pharmaceuticals (SPRY) hold meetings with investors at the conference?

Yes, company management will participate in one-on-one investor meetings during the conference.

Where will the ARS Pharmaceuticals (SPRY) webcast replay be accessible and for how long?

The replay will be archived in the Investors & Media section of the company website for 90 days.

What time is the ARS Pharmaceuticals (SPRY) fireside chat with Piper Sandler on December 3, 2025?

The fireside chat is scheduled for 2:30 pm ET on Wednesday, December 3, 2025.